Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.

Journal Article (Journal Article)

A personalized treatment strategy formalizes evidence-based treatment selection by mapping patient information to a recommended treatment. Personalized treatment strategies can produce better patient outcomes while reducing cost and treatment burden. Thus, among clinical and intervention scientists, there is a growing interest in conducting randomized clinical trials when one of the primary aims is estimation of a personalized treatment strategy. However, at present, there are no appropriate sample size formulae to assist in the design of such a trial. Furthermore, because the sampling distribution of the estimated outcome under an estimated optimal treatment strategy can be highly sensitive to small perturbations in the underlying generative model, sample size calculations based on standard (uncorrected) asymptotic approximations or computer simulations may not be reliable. We offer a simple and robust method for powering a single stage, two-armed randomized clinical trial when the primary aim is estimating the optimal single stage personalized treatment strategy. The proposed method is based on inverting a plugin projection confidence interval and is thereby regular and robust to small perturbations of the underlying generative model. The proposed method requires elicitation of two clinically meaningful parameters from clinical scientists and uses data from a small pilot study to estimate nuisance parameters, which are not easily elicited. The method performs well in simulated experiments and is illustrated using data from a pilot study of time to conception and fertility awareness.

Full Text

Duke Authors

Cited Authors

  • Laber, EB; Zhao, Y-Q; Regh, T; Davidian, M; Tsiatis, A; Stanford, JB; Zeng, D; Song, R; Kosorok, MR

Published Date

  • April 15, 2016

Published In

Volume / Issue

  • 35 / 8

Start / End Page

  • 1245 - 1256

PubMed ID

  • 26506890

Pubmed Central ID

  • PMC4777666

Electronic International Standard Serial Number (EISSN)

  • 1097-0258

Digital Object Identifier (DOI)

  • 10.1002/sim.6783


  • eng

Conference Location

  • England